Strides said to consider sale of injectable-drugs unit
11:36 EDT 10 Aug 2012 | Current Partnering
Strides Arcolab Ltd. (STR), a supplier of cancer-fighting drugs to Pfizer Inc., is considering selling its injectable-medicines unit, three people with knowledge of the matter said. The unit, called Agila Specialties, may be valued at more than Bangalore-based Strides’s current market value of about $800 million, two people said, declining to be identified as the information is [...]The post Strides said to consider sale of injectable-drugs unit appeared first on Current Partnering
Original Article: Strides said to consider sale of injectable-drugs unit
More From BioPortfolio on "Strides said to consider sale of injectable-drugs unit"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
